The Canadian Clinical Trials Asset Map (CCTAM) - Shurjeel H Choudhri and Alison Orth
-
Upload
cityage -
Category
Health & Medicine
-
view
566 -
download
2
description
Transcript of The Canadian Clinical Trials Asset Map (CCTAM) - Shurjeel H Choudhri and Alison Orth
![Page 1: The Canadian Clinical Trials Asset Map (CCTAM) - Shurjeel H Choudhri and Alison Orth](https://reader033.fdocuments.net/reader033/viewer/2022052820/54c4b1e14a79594a658b4580/html5/thumbnails/1.jpg)
The Canadian Clinical Trials Asset Map
(CCTAM)
Shurjeel H Choudhri, MD, FRCPC Senior Vice President & Head, Bayer Inc
Alison Orth, BBA, CCRC Project Management Consultant, BCCRIN
![Page 2: The Canadian Clinical Trials Asset Map (CCTAM) - Shurjeel H Choudhri and Alison Orth](https://reader033.fdocuments.net/reader033/viewer/2022052820/54c4b1e14a79594a658b4580/html5/thumbnails/2.jpg)
![Page 3: The Canadian Clinical Trials Asset Map (CCTAM) - Shurjeel H Choudhri and Alison Orth](https://reader033.fdocuments.net/reader033/viewer/2022052820/54c4b1e14a79594a658b4580/html5/thumbnails/3.jpg)
Global Patient Recruitment by Region
![Page 4: The Canadian Clinical Trials Asset Map (CCTAM) - Shurjeel H Choudhri and Alison Orth](https://reader033.fdocuments.net/reader033/viewer/2022052820/54c4b1e14a79594a658b4580/html5/thumbnails/4.jpg)
Clinical Trials by Country: Percent Change from 2005 to 2010
-20%
0%
20%
40%
60%
80%
100%
120%
140%
160%
180%
1 2
3 4 5 6 7 8 9 10 11 12 13 14 15
16
Perc
enta
ge o
f Cha
nge
Country by Rank from 1 to 16
Japan
China
Russian Confederation
Poland
Australia
Argentina
Germany
France
Brazil
India
CANADA
![Page 5: The Canadian Clinical Trials Asset Map (CCTAM) - Shurjeel H Choudhri and Alison Orth](https://reader033.fdocuments.net/reader033/viewer/2022052820/54c4b1e14a79594a658b4580/html5/thumbnails/5.jpg)
Clinical Trial Sites by Country: Percent Change from 2005 to 2010
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
16 -50%
0%
50%
100%
150%
200%
250%
Perc
enta
ge o
f Cha
nge
Country by Rank 1 to 16
Japan
India
China
Russian Confederation
Argentina
Poland
Brazil
Australia
South Africa
United Kingdom
Spain
France
CANADA
![Page 6: The Canadian Clinical Trials Asset Map (CCTAM) - Shurjeel H Choudhri and Alison Orth](https://reader033.fdocuments.net/reader033/viewer/2022052820/54c4b1e14a79594a658b4580/html5/thumbnails/6.jpg)
Health Canada CTAs
CTA = Clinical Trial Applications
![Page 7: The Canadian Clinical Trials Asset Map (CCTAM) - Shurjeel H Choudhri and Alison Orth](https://reader033.fdocuments.net/reader033/viewer/2022052820/54c4b1e14a79594a658b4580/html5/thumbnails/7.jpg)
Clinical Trial Density & Growth Rate
Nature Biotechnology January 2012
![Page 8: The Canadian Clinical Trials Asset Map (CCTAM) - Shurjeel H Choudhri and Alison Orth](https://reader033.fdocuments.net/reader033/viewer/2022052820/54c4b1e14a79594a658b4580/html5/thumbnails/8.jpg)
Initiatives in the US
TransCelerate BioPharma Initiative DrugDev.org
![Page 9: The Canadian Clinical Trials Asset Map (CCTAM) - Shurjeel H Choudhri and Alison Orth](https://reader033.fdocuments.net/reader033/viewer/2022052820/54c4b1e14a79594a658b4580/html5/thumbnails/9.jpg)
Canada’s Strengths in Clinical Trials
• High reputation of researchers, organizations & outputs
• Diverse population
• Disease & population-specific networks & health charities
• National progress on operational barriers
• Interested public
• Publically-funded healthcare & provincial funding for health
• Federal & provincial leadership
![Page 10: The Canadian Clinical Trials Asset Map (CCTAM) - Shurjeel H Choudhri and Alison Orth](https://reader033.fdocuments.net/reader033/viewer/2022052820/54c4b1e14a79594a658b4580/html5/thumbnails/10.jpg)
• The first ever clinical trial steering committee meeting (Sep 2011) • 150 experts from Government, Academia, Clinical Sites & Industry • Topics critical to the Canadian clinical trial environment:
• Ethics review process • Recruitment, patient retention & follow-up (administrative databases, e-records) • Cost structure • Administrative (contracts, standard operating procedures, education, training) • Future – what strengths can Canada develop that would make a difference in 5-10
years?
Clinical Trials Summit 2011
![Page 11: The Canadian Clinical Trials Asset Map (CCTAM) - Shurjeel H Choudhri and Alison Orth](https://reader033.fdocuments.net/reader033/viewer/2022052820/54c4b1e14a79594a658b4580/html5/thumbnails/11.jpg)
Clinical Trials Action Plan
http://www.acaho.org/?policy_2012
http://www.canadapharma.org/en/our-industry/clinical-trial-summit
![Page 12: The Canadian Clinical Trials Asset Map (CCTAM) - Shurjeel H Choudhri and Alison Orth](https://reader033.fdocuments.net/reader033/viewer/2022052820/54c4b1e14a79594a658b4580/html5/thumbnails/12.jpg)
Clinical Trials Action Plan Vision: Canada to become a premier country globally for conducting industry led clinical trials (CT)
Strategic Goals:
1. Establish short & longer term implementation capacity for this action plan & coordination of other CT improvement activities
2. Improve business operations through better cost, quality, & speed of clinical trial start-up times
3. Shape a positive future business environment & signal Canada’s interest globally with information & incentives
![Page 13: The Canadian Clinical Trials Asset Map (CCTAM) - Shurjeel H Choudhri and Alison Orth](https://reader033.fdocuments.net/reader033/viewer/2022052820/54c4b1e14a79594a658b4580/html5/thumbnails/13.jpg)
What is Canadian Clinical Trials Asset Map (CCTAM)?
Component of Strategic Goal # 3 of Action Plan
Web-based “living”, easily searchable, interactive database of Canadian clinical research capabilities
Broad umbrella of stakeholders including Rx&D & member companies, CIHR, DFAIT, Health Canada, Industry Canada, ACAHO, BCCRIN, CTO, N2 and independent research centers
![Page 14: The Canadian Clinical Trials Asset Map (CCTAM) - Shurjeel H Choudhri and Alison Orth](https://reader033.fdocuments.net/reader033/viewer/2022052820/54c4b1e14a79594a658b4580/html5/thumbnails/14.jpg)
CCTAM Objectives
Improve capacity for both the academic & commercial sectors to conduct clinical studies in Canada
Position Canada globally as an attractive destination for clinical trial investments
![Page 15: The Canadian Clinical Trials Asset Map (CCTAM) - Shurjeel H Choudhri and Alison Orth](https://reader033.fdocuments.net/reader033/viewer/2022052820/54c4b1e14a79594a658b4580/html5/thumbnails/15.jpg)
CCTAM: Design Principles • Consider from view of both end user’s & the sites • Ensure it meets evolving stakeholder
requirements
• Optimize scope & application of the tool
• Leverage & integrate experiences from existing asset maps where possible to avoid duplication of effort
![Page 16: The Canadian Clinical Trials Asset Map (CCTAM) - Shurjeel H Choudhri and Alison Orth](https://reader033.fdocuments.net/reader033/viewer/2022052820/54c4b1e14a79594a658b4580/html5/thumbnails/16.jpg)
Features of CCTAM Bilingual Comprehensive data set Regular updates Easy to search No cost to contributors to use
![Page 17: The Canadian Clinical Trials Asset Map (CCTAM) - Shurjeel H Choudhri and Alison Orth](https://reader033.fdocuments.net/reader033/viewer/2022052820/54c4b1e14a79594a658b4580/html5/thumbnails/17.jpg)
Who Stands to Benefit? Academic Research Sites Independent Research Sites Government Industry Academia Canadians
![Page 18: The Canadian Clinical Trials Asset Map (CCTAM) - Shurjeel H Choudhri and Alison Orth](https://reader033.fdocuments.net/reader033/viewer/2022052820/54c4b1e14a79594a658b4580/html5/thumbnails/18.jpg)
Progress to Date Key audiences & stakeholders identified & engaged
Existing asset maps audited to identify unmet needs & potential data sources
British Columbia Clinical Research Infrastructure Network’s (BCCRIN) Asset Map (http://assets.bccrin.ca/ is being considered as a base framework for CCTAM
Initial data points to be included identified
![Page 19: The Canadian Clinical Trials Asset Map (CCTAM) - Shurjeel H Choudhri and Alison Orth](https://reader033.fdocuments.net/reader033/viewer/2022052820/54c4b1e14a79594a658b4580/html5/thumbnails/19.jpg)
Progress to Date contd. Work underway to enhance existing BCCRIN asset
map
Agreement in principle across RX&D member companies to contribute data
Part I of communication strategy developed
![Page 20: The Canadian Clinical Trials Asset Map (CCTAM) - Shurjeel H Choudhri and Alison Orth](https://reader033.fdocuments.net/reader033/viewer/2022052820/54c4b1e14a79594a658b4580/html5/thumbnails/20.jpg)
Changing the landscape for clinical research in BC.
www.bccrin.ca
![Page 21: The Canadian Clinical Trials Asset Map (CCTAM) - Shurjeel H Choudhri and Alison Orth](https://reader033.fdocuments.net/reader033/viewer/2022052820/54c4b1e14a79594a658b4580/html5/thumbnails/21.jpg)
www.bccrin.ca
A collabora7ve partnership of provincial health
authori7es, universi7es, industry associa7ons and
funding agencies.
Focused on transforming the clinical research landscape
in BC.
Develop first in class research processes and infrastructure to support clinical research personnel
and ac7vi7es.
A@ract increased investment into BC; provide improved
access to innova7ve medicines and diagnos7cs.
This network has the poten7al to profoundly alter the clinical landscape in
Canada and become a gold standard center for clinical
research worldwide.
![Page 22: The Canadian Clinical Trials Asset Map (CCTAM) - Shurjeel H Choudhri and Alison Orth](https://reader033.fdocuments.net/reader033/viewer/2022052820/54c4b1e14a79594a658b4580/html5/thumbnails/22.jpg)
www.bccrin.ca
![Page 23: The Canadian Clinical Trials Asset Map (CCTAM) - Shurjeel H Choudhri and Alison Orth](https://reader033.fdocuments.net/reader033/viewer/2022052820/54c4b1e14a79594a658b4580/html5/thumbnails/23.jpg)
www.bccrin.ca
Online, searchable database with interactive elements Information on clinical trials investigators, sites, research units, ethics
boards in BC Captures BC biomedical, clinical, health services policy, population and
public health and medical device researchers Includes academic, institutional and community/independent sites from
across the province Industry standard: PHP, MySQL, Javascript. Allows for future updates
and extensions
www.bccrin.ca/
![Page 24: The Canadian Clinical Trials Asset Map (CCTAM) - Shurjeel H Choudhri and Alison Orth](https://reader033.fdocuments.net/reader033/viewer/2022052820/54c4b1e14a79594a658b4580/html5/thumbnails/24.jpg)
Summary CCTAM initiative only possible due to the extraordinary
participation & commitment of groups & individuals across industries, sectors & geographical locations in Canada
Significant progress over the past 18 months in developing the CCTAM
Once complete, CCTAM will be a comprehensive one-stop tool for both local & global entities considering Canada as a site for clinical research
CCTAM will continue to evolve & develop true to its living tool concept
![Page 26: The Canadian Clinical Trials Asset Map (CCTAM) - Shurjeel H Choudhri and Alison Orth](https://reader033.fdocuments.net/reader033/viewer/2022052820/54c4b1e14a79594a658b4580/html5/thumbnails/26.jpg)
Thanks! Questions?
You can tell whether a man is clever by his answers. You can tell whether a man is wise by his questions. Naguib Mahfouz